<DOC>
	<DOCNO>NCT01588743</DOCNO>
	<brief_summary>It well know Long-term hyperglycemia ( also know glucose toxicity ) contribute impairment islet β-cell function development insulin resistance . A grow body evidence also indicate impairment inβ-cell function insulin action could restore hyperglycemia correct short-term intensive insulin therapy . In study , determine use golden standard insulin sensitivity evaluation vivo—hyperinsulinemia euglycemic glucose clamp—to estimate insulin resistance improvement patient intensive insulin therapy , investigate first phase insulin secretion evaluate β-cell function , examine change insulin resistance insulin secretion result normalization plasma glucose level lean obese patient insulin pump therapy .</brief_summary>
	<brief_title>Effects Short-term Intensive Insulin Therapy Newly Diagnosed Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Age : 25 60 year old Duration diabetes : newly diagnose type 2 diabetes ( duration diabetes less 1 year ) n't take antidiabetic medication . Fasting blood glucose 11.0mmol/L . Half patient BMI 24 half BMI 24. type 1 diabetes mellitus type 2 diabetes patient intercurrent illness ( ketoacidosis , infection acute stress ) Presence autoimmune disease , hepatic renal disease concomitant disease allow . Women pregnant , breast feeding intention become pregnant within next 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>